Innovate Vs. Akero Therapeutics Industry Stock Comparison

Sell

24

VATE
Innovate

Last Price:

$5.51

Seasonality Move:

-11.75%

Buy

62

AKRO
Akero Therapeutics

Last Price:

$53.51

Seasonality Move:

13.24%

Sell

24

Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

The current Innovate [VATE] share price is $5.46. The Score for VATE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

62

Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $52.96. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VATE Stock Price Chart

What is Innovate's stock price today?

The Innovate share price today is $5.46

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VATE is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $52.96

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

VATE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.25	Sell
Relative Strength Index (14 RSI):	42.22	Sell
Chaikin Money Flow:	-4097	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.57 - 6.59)	Sell
Bollinger Bands (100):	(5.56 - 10.3)	Sell

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.22	Buy
Relative Strength Index (14 RSI):	64.34	Buy
Chaikin Money Flow:	-1115341	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.09 - 52.31)	Buy
Bollinger Bands (100):	(36.41 - 51.69)	Buy

VATE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.62	Sell
20-day SMA:	5.96	Sell
50-day SMA:	6.15	Sell
200-day SMA:	6.39	Sell
8-day EMA:	5.68	Sell
20-day EMA:	5.93	Sell
50-day EMA:	6.42	Sell
200-day EMA:	7.03	Sell

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.22	Sell
20-day SMA:	48.04	Buy
50-day SMA:	43.18	Buy
200-day SMA:	36.51	Buy
8-day EMA:	52.68	Buy
20-day EMA:	49.38	Buy
50-day EMA:	45.64	Buy
200-day EMA:	38.23	Buy

Innovate Earnings Growth & VATE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Innovate Technical Analysis

	May 29	May 30	Jun 2	Jun 3	Jun 4	Jun 5	Jun 6	Jun 9	Jun 10	Jun 11
	May			Jun
	29	30	02	03	04	05	06	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

	May 29	May 30	Jun 2	Jun 3	Jun 4	Jun 5	Jun 6	Jun 9	Jun 10	Jun 11
	May			Jun
	29	30	02	03	04	05	06	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):